Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Has The Veterinary Biologics Market Growth Evolved From 2024 To 2025, And What’s Ahead?

There has been a robust increase in the size of the veterinary biologics market in the past few years. The market size is projected to rise from $12.67 billion in 2024 to $13.61 billion in 2025, reflecting a compound annual growth rate (CAGR) of 7.4%. Animal disease epidemics, regulatory approvals and standards, requirement for food safety, global trade expansion and the economic value of livestock have all contributed to the growth during the historic period.

Predictions for the veterinary biologics market size anticipate robust growth in the coming years, with expectations to reach $18.36 billion by 2029, at a compound annual growth rate (CAGR) of 7.8%. This predicted rise during the forecast period can be associated with factors such as the prevalence of new infectious diseases, changes in climate and disease patterns, precision in livestock farming, the one health approach, and the growing trend of pet ownership. Notable trends within this forecast period encompass education and training programs, eco-friendly biologics, incorporation of digital health records, increase in biologics for companion animals, and personalized, targeted treatments.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12366&type=smp

Which Primay Drivers Are Accelerating Growth in the Veterinary Biologics Market?

The growth of the veterinary biologics market is being driven by an increase in the incidence of diseases among animals. The term “animal diseases” incorporates any health issues experienced by various species of animals. With the upsurge in such diseases comes a heightened demand for effective diagnosis and treatment, a need that can be addressed through the use of veterinary biologics, which employ immunological techniques to treat animal diseases. For example, the European Center for Disease Prevention and Control, a health agency based in Sweden and part of the European Union, reported in October 2022 that there were 2,467 instances of avian influenza outbreaks in poultry, affecting 48 million birds, with 187 cases identified in captive birds. Additionally, the World Health Organization, a Switzerland-based specialized UN agency, revealed in July 2022 that annually, rabies claims 59,000 lives in over 150 countries, 95% of which occur in Africa and Asia. Consequently, the escalating rates of animal diseases are fuelling the demand for veterinary biologics.

Which Primary Segments of the Veterinary Biologics Market Are Driving Growth and Industry Transformations?

The veterinary biologics market covered in this report is segmented –

1) By Product: Vaccines, Diagnostic Kits, Immunomodulators, Antiserums And Antibodies, Other Products

2) By Disease Type: Bluetongue, Foot And Mouth Disease, Brucellosis And Tuberculosis, Other Diseases

3) By Distribution Channel: Veterinary Hospitals, Veterinary Clinics, Other Distribution Channels

4) By Application: Production Animal, Companion Animal

Subsegments:

1) By Vaccines: Live Attenuated Vaccines, Inactivated Vaccines, Recombinant Vaccines, DNA Vaccines

2) By Diagnostic Kits: Rapid Tests, Elisa Kits, Pcr-Based Diagnostic Kits

3) By Immunomodulators: Cytokines, Adjuvants, Immunostimulants

4) By Antiserums And Antibodies: Monoclonal Antibodies, Polyclonal Antibodies, Hyperimmune Serums

5) By Other Products: Probiotics, Prebiotics, Growth Factors, Toxoids

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=12366&type=smp

Which Regions Are Key Players in the Growth of the #Which Primay Drivers Are Accelerating Growth in the Veterinary Biologics Market?# Market?

North America was the largest region in the veterinary biologics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the veterinary biologics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Which Technological Trends Are Reshaping the Veterinary Biologics Industry Dynamics?

Key players in the veterinary biologics market are focusing their efforts on creating innovative biologics such as vaccines to improve animal health and prevent diseases. Vaccines are substances that trigger the immune system to identify and combat specific pathogens, thereby preventing infectious diseases by promoting acquired immunity. Merck Animal Health, a renowned global animal health company based in the US, unveiled a pioneering autogenous vaccine focused on avian metapneumovirus (aMPV) type B in August 2024. This was done with USDA approval for production and selling. This vaccine, a joint venture with Cambridge Technologies, intends to battle the severe respiratory conditions triggered by aMPV type B in birds, which has resulted in substantial economic damage since late 2023. The vaccine is produced at a state-of-the-art facility in Minnesota, utilizing an oil and water emulsion formulation to reduce tissue reactions after vaccination. This fills a crucial void in the market as no commercially licensed vaccines were previously available.

View the full report here:

https://www.thebusinessresearchcompany.com/report/veterinary-biologics-global-market-report

What Parameters Are Used to Define the Veterinary Biologics Market?

Veterinary biologics refers to biological products derived from living organisms, such as bacteria, viruses, or other microorganisms. Veterinary biologics are used in veterinary medicine to prevent, diagnose, or treat animal diseases.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12366

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model